Today KALV ranks # as BUY CANDIDATE.
Today KALV ranks # as BUY CANDIDATE.

KALV stock KalVista Pharmaceuticals Inc

KALV stock
KalVista Pharmaceuticals Inc

February 14, 2019
Change 1.87%
Chart period: 2018-11-15 - 2019-02-14





Will KALV stock price go up or down on Mon, 18 Feb 2019?

KalVista Pharmaceuticals Inc Forecast and Stock Analysis

Technical KALV stock analysis for February 14, 2019.

Buy candidate since 2019-02-13 Gain 1.87%
Shorts n/a
Cash n/a
Loans n/a
Beta 2.38
ROA -17.09

KalVista Pharmaceuticals Inc gained 1.87% in the last trading day, rising from $19.24 to $19.60 , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has risen in 6 of the last 10 days and is up by 4.87% over the past 2 weeks. Volume fell in the last day by -22 172 shares, and in total, 18 384 shares bought and sold for approximately $360 326.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Close price at the end of the last trading day (Thursday, 14th Feb 2019) of the KALV stock was $19.60. This is 1.87% more than the trading day before Wednesday, 13th Feb 2019.

During day the stock fluctuated 4.19% from a day low at $19.08 to a day high of $19.88.

30 day high of the KALV stock price was $20.25 and low was $16.16.
90 day high was $25.57 and low was $16.16.
52 week high for the KalVista Pharmaceuticals Inc - $25.57 and low - $7.73.


KalVista Pharmaceuticals Inc lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $20.78 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -17.78% during the next 3 months and, with 90% probability hold a price between $11.82 and $17.08 at the end of this period.

Click here for today's Top 5 Trending Companies


KalVista Pharmaceuticals Inc holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $19.03 and $18.73. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday February 07, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 63 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

KalVista Pharmaceuticals Inc finds support from accumulated volume at $19.56.

Support: $19.56 Price: $19.60 Resistance: $22.40


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.80 between high and low, or 4.19%. For the last week the stock has had a daily average volatility of 4.61%.

Our recommended stoploss: $18.81 (-4.04%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 5 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation: Buy Candidate

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Today KALV ranks # as BUY CANDIDATE.
Today KALV ranks # as BUY CANDIDATE.